Conflict of interest
Keishi Fujio received financial support or fees from Astellas, Daiichi-Sankyo, MitsubishiTanabe, Pfizer, Santen, Eisai, Taisho Toyama, UCB, Janssen, BMS, Takeda, and Chugai.
Kazuhiko Yamamoto received financial support or fees from AbbVie, Astellas, BMS, Daiichi-Sankyo, MitsubishiTanabe, Pfizer, Sanofi, Santen, Takeda, Teijin, Boehringer Ingelheim, Chugai, Eisai, Ono, Taisho Toyama, UCB, ImmunoFuture, Asahi Kasei, and Janssen.
All other authors declare no competing financial interests.